Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alidac Pharmaceuticals is a key subsidiary of Zydus Lifesciences, one of India's premier pharmaceutical organizations. The company is primarily engaged in the manufacturing and commercialization of a broad spectrum of pharmaceutical formulations, with a strong presence in therapeutic areas such as gastroenterology, respiratory health, and anti-infectives. Alidac operates advanced manufacturing facilities that adhere to global quality standards, ensuring the delivery of safe and effective medications to diverse markets. As an integral part of the Zydus group, the company supports the parent organization's mission of providing affordable healthcare solutions through a robust portfolio of generic and branded products. Alidac's strategic focus on operational excellence and market expansion has established it as a reliable provider in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alidac.